Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot Study
Status:
Withdrawn
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
NIL-2 is a clinical trial designed to evaluate the efficacy and safety of low doses of
Interleukin2 in the treatment of recently diagnosed, steroid dependent idiopathic nephrotic
syndrome in children. Recent data suggest that Interleukin 2 could be an effective therapy
via an increased production of regulatory T cells.